Quantitative Ultrasound for Assessment of Placental Structure During the Development of Preeclampsia
定量超声评估先兆子痫发展过程中的胎盘结构
基本信息
- 批准号:10790437
- 负责人:
- 金额:$ 44.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-22 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteBlood VesselsBlood flowClinicClinicalClinical assessmentsDeciduaDedicationsDevelopmentDiagnosisDiscipline of obstetricsDisease ProgressionDoppler UltrasoundEarly DiagnosisEarly InterventionElasticityEndometriumEtiologyFetal healthFibrosisFirst Pregnancy TrimesterFundingFunding OpportunitiesFutureGoalsGrowthHealthHistopathologyHumanImageImaging DeviceInjuryInvadedKnowledgeMagnetic Resonance ImagingMaternal HealthMedical ImagingMedicineMethodsMissionModelingNew YorkOutcomePatient-Focused OutcomesPerfusionPlacentaPlacental InsufficiencyPlacentationPre-EclampsiaPregnancyPreventionProcessPropertyProteinuriaPublic HealthRattusResearchResolutionResourcesRiskRodent ModelScreening procedureSeveritiesSignal TransductionStructureSystemTestingTimeTissuesUltrasonographyUnited States National Institutes of HealthUniversitiesUterusValidationWomanWorkattenuationclinical translationcosteffective therapyelastographyendothelial dysfunctionfetalimaging modalityimprovedimproved outcomein vivoin vivo imagingmaternal hypertensionnovelnovel strategiespoint of carepressurequantitative ultrasoundradio frequencyresponsesoft tissuestatisticssuccesstissue injurytoolultrasound
项目摘要
PROJECT SUMMARY
A lack of effective treatments for preeclampsia persists due, in part, to our inability to detect altered placental
tissue microstructure as an indicator of abnormal placental development. This application proposes a MPI
collaborative study to be performed by Weill Cornell Medicine (WCM) in New York, NY and Tulane University
(TU) in New Orleans, LA. The proposed project is responsive to the Human Placenta Project PAR-22-236
and seeks to develop a novel ultrasound approach for “safe, real-time, and non-invasive” assessment of “the
development … of the human placenta across pregnancy”. Our long-term goal is to develop imaging tools to
improve outcomes in women with preeclampsia. The overall objective of this proposal is to develop and
validate quantitative ultrasound (QUS) to detect and correlate microstructural alterations in the placenta with
preeclampsia. QUS uses radio-frequency (RF) US signals to characterize soft tissues quantitatively. We
hypothesize that QUS-based parameters will be capable of quantifying the microstructural changes which
characterize preeclampsia. Guided by a strong scientific premise, this hypothesis will be tested by pursing
two specific aims: 1) To quantify altered human placental microstructure ex vivo; and 2) To assess placental
microstructure longitudinally in vivo in an established rodent model of preeclampsia. Under the first aim, we
will develop QUS methods to characterize the human placenta and test the hypothesis that specific QUS
parameters will correlate with altered vascular development and injury in the ex vivo human preeclamptic
placenta, with histopathology as the gold standard. The second aim will test the hypothesis that QUS
parameters will correlate with microstructural and changes due to altered vasculature and fibrosis in the
reduced uterine perfusion pressure rat model of preeclampsia. The expected outcome of this work will be
the validation of QUS-derived parameters for the assessment of placental microstructure. With these imaging
methods, we anticipate correlating specific QUS parameters related to placental microstructure with the
diagnosis of preeclampsia. This outcome will strongly motivate the dedication of additional resources for
clinical translation and in vivo longitudinal validation of QUS to earlier detect and predict severity of
preeclampsia in women. Consistent with the goals of this funding opportunity and the goals of the HPP, this
work will lead to the development of a new point-of-care ultrasound assessment of preeclampsia risk and
severity, which can be accomplished using the ultrasound systems existing in the clinic.
项目概要
先兆子痫仍然缺乏有效的治疗方法,部分原因是我们无法检测胎盘的改变
组织微观结构作为异常胎盘发育的指标本申请提出了 MPI。
纽约威尔康奈尔医学院 (WCM) 和杜兰大学将进行合作研究
(TU),路易斯安那州新奥尔良 拟议项目响应人类胎盘项目 PAR-22-236。
并寻求开发一种新颖的超声方法,用于“安全、实时和非侵入性”评估“
怀孕期间人类胎盘的发育……我们的长期目标是开发成像工具
改善先兆子痫女性的预后 该提案的总体目标是制定和实施。
验证定量超声 (QUS) 检测胎盘微观结构变化并将其与
QUS 使用射频 (RF) US 信号来定量表征软组织。
基于 QUS 的参数将能够量化微观结构的变化,
在强有力的科学前提的指导下,这一假设将得到检验。
两个具体目标:1) 量化体外胎盘微观结构的改变;2) 评估胎盘
在第一个目标下,我们在已建立的先兆子痫啮齿动物模型中纵向观察体内微观结构。
将开发 QUS 方法来表征人类胎盘并测试特定 QUS 的假设
参数将与离体人类先兆子痫的血管发育和损伤的改变相关
胎盘,以组织病理学为金标准,第二个目标将检验 QUS 的假设。
参数将与微观结构以及由于脉管系统和纤维化改变而引起的变化相关
子痫前期子宫灌注压降低大鼠模型这项工作的预期结果是。
通过这些成像来验证 QUS 衍生参数用于评估胎盘微观结构。
方法,我们预计将与胎盘微观结构相关的特定 QUS 参数与
这一结果将强烈激励我们投入更多资源。
QUS 的临床转化和体内纵向验证,可及早检测和预测疾病的严重程度
女性先兆子痫与本次资助机会的目标和 HPP 的目标一致。
这项工作将导致开发一种新的针对先兆子痫风险的护理点超声评估
严重程度,这可以使用诊所现有的超声系统来完成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolyn Louise Bayer其他文献
Carolyn Louise Bayer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carolyn Louise Bayer', 18)}}的其他基金
Placental Functional Imaging to Predict Preeclampsia Therapeutic Outcomes
胎盘功能成像预测先兆子痫的治疗结果
- 批准号:
10680400 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别:
Placental Functional Imaging to Predict Preeclampsia Therapeutic Outcomes
胎盘功能成像预测先兆子痫的治疗结果
- 批准号:
10440310 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别:
Placental Functional Imaging to Predict Preeclampsia Therapeutic Outcomes
胎盘功能成像预测先兆子痫的治疗结果
- 批准号:
10215581 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别:
Placental Functional Imaging to Predict Preeclampsia Therapeutic Outcomes
胎盘功能成像预测先兆子痫的治疗结果
- 批准号:
10011931 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别:
Placental Functional Imaging to Predict Preeclampsia Therapeutic Outcomes
胎盘功能成像预测先兆子痫的治疗结果
- 批准号:
10680400 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别:
Molecular Photoacoustic Imaging using Multitargeted Contrast Agents
使用多靶点造影剂的分子光声成像
- 批准号:
8528387 - 财政年份:2011
- 资助金额:
$ 44.26万 - 项目类别:
Molecular Photoacoustic Imaging using Multitargeted Contrast Agents
使用多靶点造影剂的分子光声成像
- 批准号:
8203467 - 财政年份:2011
- 资助金额:
$ 44.26万 - 项目类别:
Molecular Photoacoustic Imaging using Multitargeted Contrast Agents
使用多靶点造影剂的分子光声成像
- 批准号:
8366277 - 财政年份:2011
- 资助金额:
$ 44.26万 - 项目类别:
相似国自然基金
血管内皮细胞通过E2F1/NF-kB/IL-6轴调控巨噬细胞活化在眼眶静脉畸形中的作用及机制研究
- 批准号:82301257
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
结合诱导纤维生成肽长效抑制角膜新生血管形成治疗角膜病的机制
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
基于中医舌诊参数及糖脂代谢指标的PCI术后再发心血管不良事件时间序列预测模型研究
- 批准号:82374336
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NETs通过m6A修饰lncRNA-H19调控内皮细胞铁死亡介导糖尿病足血管新生障碍的机制研究
- 批准号:82370497
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Increasing muscle mass resolves vascular dysfunction in obesity
增加肌肉质量可以解决肥胖症的血管功能障碍
- 批准号:
10679363 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
PET Tracer for Imaging of Lung Inflammation
用于肺部炎症成像的 PET 示踪剂
- 批准号:
10682270 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
The protective function of blood-borne monocytes/macrophages after delayed recanalization in a permanent MCAO rodent model
永久性 MCAO 啮齿动物模型延迟再通后血源性单核细胞/巨噬细胞的保护功能
- 批准号:
10806832 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
Optogenetic and chemogenetic regulation of uterine vascular function
子宫血管功能的光遗传学和化学遗传学调控
- 批准号:
10785667 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
Hemorrhagic transformation associated with delayed reperfusion in perinatal and childhood ischemic stroke: brain maturation-dependent role of leukocytes
与围产期和儿童缺血性卒中延迟再灌注相关的出血性转化:白细胞的脑成熟依赖性作用
- 批准号:
10811475 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别: